Accurate ligand high-affinity determination
Johan Engström, Senior Scientist at Gyros Protein Technologies, discusses the challenges of measuring high-affinity interactions of ligands in cancer immunotherapy
Johan Engström, Senior Scientist at Gyros Protein Technologies, discusses the challenges of measuring high-affinity interactions of ligands in cancer immunotherapy
The acquisition allows full-scale entry into the global life sciences business
Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis
The Simple Plex AAV2 assay combines the scalability and automation of Ella with best-in-class AAV reagents from PROGEN
This week, explore topics ranging from fluorescence, confocal and TIRF microscopy to checkpoint inhibitor therapeutics
Northumbria University team hopes research will lead to more energy-efficient phone and TV screens
Both multi-mode readers feature a modular architecture so that researchers may purchase based on their immediate needs and upgrade the unit
The Synthetic Brain Project is using AI models powered by the Cambridge-1 supercomputer
Asynt's popular fReactor platform offers chemists an affordable entry point into the world of flow chemistry
Achieve up to 10x higher throughput plus even better image quality with new DeepRecon Pro and PhaseEvolve modules from ZEISS
Dr. Dallas Flies, Vice President, Discovery Research, NextCure, Inc. discusses the cutting-edge technology transforming the identification of new targets for the development of effective immunotherapeutics
The agreement will provide prevalidated hepatocytes for use on innovative organ-on-a-chip range